2019
Comparison of bone lesion distribution between prostate cancer and multiple myeloma with whole-body MRI
Larbi A, Omoumi P, Pasoglou V, Michoux N, Triqueneaux P, Tombal B, Cyteval C, Lecouvet FE
Journal: Diagnostic and Interventional Imaging
Volume: 100, Issue 5
Année: Mai 2019
Pages: 295-302
Effets osseux des traitements de bisphosphonates et dénosumab en cas de cancer du sein ou de la prostate [Bone effects of bisphosphonates and denosumab treatments in breast or prostate cancer]
Biver E
Journal: Revue Médicale Suisse
Volume: 15
Année: Avril 2019
Pages: 824-830
https://www.revmed.ch/RMS/2019/RMS-N-647/Effets-osseux-des-traitements-de-bisph…
Bone metastases from lung cancer: A paradigm for multidisciplinary onco-rheumatology management
Confavreux CB, Pialat JB, Bellière A, Brevet M, Decroisette C, Tescaru A, Wegrzyn J, Barrey C, Mornex F, Souquet PJ, Girard N
Journal: Joint Bone Spine
Volume: 86, Issue 2
Année: Mars 2019
Pages: 185-194
ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors
Vargas G, Bouchet M, Bouazza L, Reboul P, Boyault C, Gervais M, Kan C, Benetollo C, Brevet M, Croset M, Mazel M, Cayrefourcq L, Geraci S, Vacher S, Pantano F, Filipits M, Driouch K, Bieche I, Gnant M, Jacot W, Aubin JE, Duterque-Coquillaud M, Alix-Panabières C, Clézardin P, Bonnelye E.
Journal: Oncogene
Volume: 38, Issue 7
Année: Novembre 2019
Pages: 950-964
Intracardiac cement embolism during percutaneous vertebroplasty: incidence, risk factors and clinical management
Fadili Hassani S, Cormier E, Shotar E, Drir M, Spano JP, Morardet L, Collet JP, Chiras J, Clarençon F.
Journal: European Radiology
Volume: 29, Issue 2
Année: Février 2019
Pages: 663-673
A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe
Body JJ, von Moos R, Rider A, Hallworth P, Bhowmik D, Gatta F, Hechmati G, Qian Y
Journal: Journal of Bone Oncology
Volume: 14
Année: Février 2019
Pages:100212
French recommendations for osteoporosis prevention and treatment in patients with prostate cancer treated by androgen deprivation
Briot K, Paccou J, Beuzeboc P, Bonneterre J, Bouvard B, Confavreux CB, Cormier C, Cortet B, Hannoun-Lévi JM, Hennequin C, Javier RM, Lespessailles E, Mayeur D, Mongiat Artus P, Vieillard MH, Debiais F
Journal: Joint Bone Spine
Volume: 86, Issue 1
Année: Janvier 2019
Pages: 21-28
2018
TMPRSS2:ERG gene fusion expression regulates bone markers and enhances the osteoblastic phenotype of prostate cancer bone metastases
Delliaux C, Tian TV, Bouchet M, Fradet A, Vanpouille N, Florens A, Deplus R, Villers A, Leroy X, Clézardin P, De Launoit Y, Bonnelye E, Duterque-Coquillaud M
Journal: Cancer Letters
Volume: 438
Année: Décembre 2018
Pages: 32-43
Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion
Body JJ, von Moos R, Niepel D, Tombal B
Journal: BMC Urology
Volume: 18, Issue 1
Année: Septembre 2018
Pages: 81
Isolation of circulating tumor cells in a preclinical model of osteosarcoma: Effect of chemotherapy
Chalopin A, Tellez-Gabriel M, Brown HK, Vallette F, Heymann MF, Gouin F, Heymann D
Journal: Journal of Bone Oncology
Volume: 12
Année: Septembre 2018
Pages: 83-90